Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials-Reference-Cited by-同舟云学术

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Published:2021-10 Issue:10 Volume:9 Page:653-662
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Sattar Naveed,Lee Matthew M Y,Kristensen Søren L,Branch Kelley R H,Del Prato Stefano,Khurmi Nardev S,Lam Carolyn S P,Lopes Renato D,McMurray John J V,Pratley Richard E,Rosenstock Julio,Gerstein Hertzel C

Funder

British Heart Foundation

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Future glucose-lowering drugs for type 2 diabetes;Bailey;Lancet Diabetes Endocrinol,2016

2. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials;Kristensen;Lancet Diabetes Endocrinol,2019

3. Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes;Gerstein;N Engl J Med,2021

4. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetes Care,2018

5. 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

Cited by 664 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact;Matrix Biology;2024-12

3. Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist;Gynecologic Oncology;2024-11

4. The advancing role of fluorogens with AIE characteristics in drug screening;TrAC Trends in Analytical Chemistry;2024-11

5. Investigating the research trajectory and future trends of immune disorders in diabetes cardiovascular complications: A bibliometric analysis over the past decade based on big data;Ageing Research Reviews;2024-11